AGP Executive Report
Last update: 10 hours agoPharma Investment & Access: Swiss firms are accelerating US spending after a trade deal cut tariffs on Swiss goods from 39% to 15%, with Roche pledging $50B and Novartis $23B—an update that also matters for Liechtenstein via the customs union. Cancer Care Update: The European Commission approved Opdivo (nivolumab) plus AVD chemotherapy as the first immunotherapy-based regimen in the EU for newly diagnosed advanced classical Hodgkin lymphoma in patients aged 12+—a meaningful step for treatment options. Space Health Research: Nevis launched the Caribbean’s first space life sciences experiment, developed with the University of Zurich and CSA Switzerland and Liechtenstein, to study how gravity changes affect human immune cells and gene expression. Local Wellness Tech: Fi expanded AI-powered GPS pet wearables to 38 countries, including Switzerland and Liechtenstein, pairing health insights with real-time tracking for pet owners on the move. Travel Health Practicalities: A UK travel warning highlights that without a GHIC card, travellers may miss state-provided medical treatment abroad at local cost, so applying before travel is key.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
